Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
about
A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functionsMerlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm MaturationRegulation of localization and function of the transcriptional co-activator YAP by angiomotin.Optimizing biologically targeted clinical trials for neurofibromatosis.In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinomaThe hippo-yes association protein pathway in liver cancerMammalian Hippo pathway: from development to cancer and beyond.Regulation of leg size and shape: involvement of the Dachsous-fat signaling pathway.Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy.Schwannomas and their pathogenesis.Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.The Fat/Hippo signaling pathway links within-disc morphogen patterning to whole-animal signals during phenotypically plastic growth in insects.Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.Mutual regulation of the Hippo/Wnt/LPA/TGF‑β signaling pathways and their roles in glaucoma (Review).[Hippo-YAP signaling pathway in the liver: more than a size gatekeeper!].
P2860
Q24299493-2096C579-89F0-4A1F-A982-2E3AAF603CE1Q27304868-5096F83D-C696-4015-855A-C9527C1B4471Q30352874-C4E148FC-9627-43EB-BB8F-86692C93C260Q30438898-9A77EFDD-424E-4F67-99BB-0AEC7A60C4A4Q35111282-2B7445BA-BC1A-4E5A-8FB2-5ABD63DDC606Q35742770-79E19C2B-2E8D-4F60-8ED8-44428A16B727Q36881080-587305BE-FCFA-4AB3-B72F-7E4690989585Q37108727-6EA0E958-6EB6-4396-AA37-0B66B4163491Q37843031-51A0B075-9A05-48AB-8918-BBA461800B2FQ37848309-27C1AB0C-F575-4CB0-89E1-F9A73FC6C136Q37880216-BB6E687A-FE8B-4B87-BD3E-B950CEA46E43Q38171966-4831E901-854B-4452-8A8F-F51EF0776E27Q38180808-560D7251-560A-4011-A111-01FD71D784F1Q39811088-1410C7D2-BDC8-4DF8-B45F-208932754C8FQ40914832-00A0CCE6-9BD7-4606-A5B4-96139DFE5943Q41206487-2CF4F578-A6EE-4584-8054-2E9BC3FBB6E5Q46412577-21E43418-5148-4A5E-835A-8A9E6D50EB4BQ47212698-EFEDD678-E840-4421-810A-94C2BF3FA561Q52721189-EB0ED881-E383-4DD6-9A5A-F59754560B66
P2860
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
@en
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
@nl
type
label
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
@en
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
@nl
prefLabel
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
@en
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
@nl
P2860
P356
P1433
P1476
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
@en
P2093
Chunling Yi
Joseph L Kissil
P2860
P304
P356
10.1101/GAD.1964810
P577
2010-08-01T00:00:00Z